|
Hypoadiponectinemia
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
|
Hypoadiponectinemia
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Adiponectin Deficiency
|
0.370 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Cardiovascular Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
<b>Background:</b> Adiponectin has been suggested as a marker of many cardiovascular diseases.
|
31088901 |
2019 |
|
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Background:</b> Insulin, IGF axis, adiponectin, and inflammatory markers are associated with breast cancer.
|
27742668 |
2017 |
|
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Background:</b> Insulin, IGF axis, adiponectin, and inflammatory markers are associated with breast cancer.
|
27742668 |
2017 |
|
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
<b>Background:</b> Studies examining associations between circulating concentrations of C-peptide and total adiponectin, two biomarkers related to obesity and insulin secretion and sensitivity and pancreatic ductal adenocarcinoma (PDA) risk have shown inconsistent results and included limited numbers of smokers.<b>Methods:</b> We examined associations of these biomarkers and high molecular weight (HMW) adiponectin with PDA, overall, and by smoking status.
|
28096201 |
2017 |
|
Pancreatic Ductal Adenocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Background:</b> Studies examining associations between circulating concentrations of C-peptide and total adiponectin, two biomarkers related to obesity and insulin secretion and sensitivity and pancreatic ductal adenocarcinoma (PDA) risk have shown inconsistent results and included limited numbers of smokers.<b>Methods:</b> We examined associations of these biomarkers and high molecular weight (HMW) adiponectin with PDA, overall, and by smoking status.
|
28096201 |
2017 |
|
Tumor Progression
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
<b>Background:</b> Using a secondary data analysis from randomized controlled trials comparing one year of resistance exercise (<i>n</i> = 109) to a placebo control condition (<i>n</i> = 106) in postmenopausal, posttreatment breast cancer survivors, we investigated the influence of resistance training and changes in body composition on markers associated with cancer progression.<b>Methods:</b> Measures included serum levels of insulin, IGF-1, IGFBP1-3, leptin, serum amyloid A (SAA), adiponectin, C-reactive protein (CRP), IL1β, TNFα, IL6, and IL8, and body composition (total, lean and fat mass in kg) by DXA at baseline, 6, and 12 months.
|
29141853 |
2018 |
|
Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
<b>Conclusion</b>: Low circulating adiponectin could be a predictive or risk factor for RCC.
|
31215811 |
2019 |
|
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
<b>Conclusion</b>: Low circulating adiponectin could be a predictive or risk factor for RCC.
|
31215811 |
2019 |
|
Obesity
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
<b>Conclusion:</b> Adiponectin rs1501299 polymorphism might be a candidate gene, which determines the susceptibility to obesity.
|
31502880 |
2019 |
|
Cerebrovascular Disorders
|
0.030 |
AlteredExpression
|
group |
BEFREE |
<b>Conclusion:</b> According to the novel study, it was suggested that elevated serum leptin as well as visfatin and decreased adiponectin levels may be a sign of cerebrovascular disease and as part of the response occurring in stroke patients.
|
30892950 |
2019 |
|
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Conclusion:</b> Elevated levels of CTRP15 in CAD patients and the relation of CTRP15 with pathogenic conditions such as insulin resistance, inflammation, and decreased adiponectin and HDL-C suggest a possible compensatory response to these conditions in CAD patients.
|
31608708 |
2019 |
|
Heart failure
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
<b>Methods:</b> Adiponectin circulating levels were determined by ELISA at discharge in patients admitted for <i>de novo</i> HF (n=74).
|
29559829 |
2018 |
|
Congestive heart failure
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
<b>Methods:</b> Adiponectin circulating levels were determined by ELISA at discharge in patients admitted for <i>de novo</i> HF (n=74).
|
29559829 |
2018 |
|
Non-alcoholic Fatty Liver Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
<b>Methods:</b> A total of 203 children and adolescents aged 5-18 years were enrolled, and their anthropometric data, body composition, liver ultrasound score for NAFLD (range, 0-6), biochemical test results, and FGF-21, leptin, and adiponectin levels were analyzed.
|
31750276 |
2019 |
|
Cardiovascular Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
(1) Serum adiponectin levels were negatively correlated with numerous CVD risk factors (all P<0.05), and following adjustments for confounding factors, a lower adiponectin level was an independent risk factor for MetS (odds ratio=5.59; 95% confidence interval: 1.90, 16.41).
|
25074391 |
2015 |
|
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
(https://doi.org/10.1084/jem.20181288) identify reduced adiponectin levels as responsible for the increased incidence of HCC in males.
|
31000682 |
2019 |
|
Atherosclerosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
1897 participants enrolled in the Multi-Ethnic Study of Atherosclerosis underwent computed tomography to quantify body composition and measurements of adiponectin, leptin, interleukin-6 (IL-6), C-reactive protein (CRP), and resistin.
|
30213651 |
2019 |
|
Arteriosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
1897 participants enrolled in the Multi-Ethnic Study of Atherosclerosis underwent computed tomography to quantify body composition and measurements of adiponectin, leptin, interleukin-6 (IL-6), C-reactive protein (CRP), and resistin.
|
30213651 |
2019 |
|
Diabetes Mellitus
|
0.400 |
AlteredExpression
|
group |
BEFREE |
2) In contrast to previous studies, the presence of diabetes does not influence adiponectin serum levels after correction for BMI.
|
15239024 |
2004 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
2) In contrast to previous studies, the presence of diabetes does not influence adiponectin serum levels after correction for BMI.
|
15239024 |
2004 |
|
Cardiovascular Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
807 individuals (35-54 years) without obesity, diabetes or cardiovascular disease was stratified into quartiles of NC (cut-off for men: 36.5; 37.9 and 39.5 cm; women: 31.4; 32.5 and 34 cm) and traditional and non-traditional risk factors (lipoprotein subfractions by Vertical Auto Profile, adiponectin, leptin, E-selectin) were compared across groups.
|
30479668 |
2018 |
|
Hypoadiponectinemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter.
|
16801592 |
2006 |